Beyond fluorescence intensity: a Minimum acquisition and reporting standard and emerging technologies for colorectal indocyanine green fluorescence angiography studies - Scorecard - MDSpire
Advertisement
Beyond fluorescence intensity: a Minimum acquisition and reporting standard and emerging technologies for colorectal indocyanine green fluorescence angiography studies
Clinical Scorecard: Establishing a Standard for Acquisition and Reporting: Advancements in Colorectal Indocyanine Green Fluorescence Angiography Techniques Beyond Fluorescence Intensity
At a Glance
Category
Detail
Condition
Colorectal Indocyanine Green Fluorescence Angiography
Key Mechanisms
Assessment of bowel perfusion during colorectal anastomosis using ICG-FA.
Target Population
Patients undergoing colorectal surgery, particularly those at risk for anastomotic leaks.
Care Setting
Intraoperative assessment during colorectal surgical procedures.
Key Highlights
ICG-FA is increasingly used to assess bowel perfusion during colorectal anastomosis.
Pooled randomized evidence supports overall benefit, especially in left-sided and rectal surgeries.
Standardization of acquisition and reporting protocols is necessary for reproducibility.
Visual interpretation of ICG-FA shows substantial interobserver variability.
Emerging metrics like time ratio (TR) may provide more reliable assessments.
Guideline-Based Recommendations
Diagnosis
Utilize ICG-FA to evaluate anastomotic perfusion.
Management
Implement standardized protocols for ICG-FA acquisition and reporting.
Monitoring & Follow-up
Assess physiological status and imaging conditions during ICG-FA.
Risks
Consider multifactorial aspects of anastomotic healing beyond perfusion.
Patient & Prescribing Data
Patients undergoing colorectal surgery with risk of anastomotic leaks.
ICG-FA should be viewed as an intraoperative safety measure rather than a standalone prevention strategy.
Clinical Best Practices
Adopt a minimum acquisition and reporting standard for ICG-FA studies.
Incorporate time-intensity kinetics and spatial heterogeneity measures in assessments.
Differentiate between perfusion measurement and perfusion biology in clinical evaluations.
